548 Folgen

  1. A Heart Attack that Led to a Rare Disease Diagnosis

    Vom: 30.1.2025
  2. Targeting Rare Liver Diseases with Gene Editing Therapies

    Vom: 23.1.2025
  3. Using AI to De-Risk Rare Disease Drug Development

    Vom: 16.1.2025
  4. Addressing a Growing Demand for Plasma-Derived Therapies

    Vom: 9.1.2025
  5. Empowering Patients with Data to Drive Drug Development

    Vom: 2.1.2025
  6. How Advocates Are Advancing a Treatment for an Ultra-Rare Disease

    Vom: 26.12.2024
  7. Engineering B Cells to Produce Therapeutic Proteins

    Vom: 19.12.2024
  8. A Pipeline Win as BridgeBio Learns to Balance Theory with Practice

    Vom: 12.12.2024
  9. Considering What It Will Take for Payers to Embrace Advances in Sequencing

    Vom: 5.12.2024
  10. Finding Strength

    Vom: 27.11.2024
  11. A Non-Profit Works to Advance a DMD Gene Therapy

    Vom: 21.11.2024
  12. Accepting What We Can’t Understand

    Vom: 14.11.2024
  13. A Gene Therapy Company Born from a Father’s Efforts to Save his Daughter

    Vom: 7.11.2024
  14. Lowering Barriers to Clinical Trial Participation with Do-It-Yourself Blood Sample Collection

    Vom: 31.10.2024
  15. Scaling N-of-1 Therapies to Viability

    Vom: 24.10.2024
  16. Building Gene Therapies that Address Gain and Loss of Function Simultaneously

    Vom: 17.10.2024
  17. How One Woman Climbed from Patient to Advocate

    Vom: 10.10.2024
  18. Shortening the Diagnostic Odyssey

    Vom: 3.10.2024
  19. Making Exomes More Revealing

    Vom: 26.9.2024
  20. How One Patient Organization Catalyzed Drug Development

    Vom: 19.9.2024

2 / 28

RARECast is a Global Genes podcast hosted by award-winning journalist Daniel Levine. It focuses on the intersection of rare disease with business, science, and policy.

Visit the podcast's native language site